Evidence map›Paper›PMID 29242021›Full record

ReviewBioorganic & medicinal chemistry2018

Activatable fluorescent probes in fluorescence-guided surgery: Practical considerations.

Ai Mochida, Fusa Ogata, Tadanobu Nagaya, Peter L Choyke, Hisataka Kobayashi

Abstract readReview
In one paragraph

Review in Bioorganic & medicinal chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. The Evolution of Fluorescence-Guided Surgery.Molecular imaging and biology · 2023
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Fluorescence Image-Guided Surgery - a Perspective on Contrast Agent Development.Proceedings of SPIE--the International Society for Optical Engineering · 2020
    Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ai MochidaMolecular Imaging Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, United States.
Fusa OgataMolecular Imaging Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, United States.
Tadanobu NagayaMolecular Imaging Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, United States.
Peter L ChoykeMolecular Imaging Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, United States.
Hisataka KobayashiMolecular Imaging Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, United States. Electronic address: kobayash@mail.nih.gov.

Funding

Growth Factor Imaging and PhotoimmunotherapyZIABC010656 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CHOYKE, PETER L · 2009 to 2024
$31.6M
Activatable molecular cancer imaging probeZIABC011512 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KOBAYASHI, HISATAKA · 2013 to 2025
$2.7M
Intramural NIH HHS Z99 CA999999Intramural NIH HHS ZIA BC011512
6 · The paper itself

Abstract

Fluorescence-guided imaging during surgery is a promising technique that is increasingly used to aid surgeons in identifying sites of tumor and surgical margins. Of the two types of fluorescent probes, always-on and activatable, activatable probes are preferred because they produce higher target-to-background ratios, thus improving sensitivity compared with always-on probes that must contend with considerable background signal. There are two types of activatable probes: 1) enzyme-reactive probes that are normally quenched but can be activated after cleavage by cancer-specific enzymes (activity-based probes) and 2) molecular-binding probes which use cancer targeting moieties such as monoclonal antibodies to target receptors found in abundance on cancers and are activated after internalization and lysosomal processing (binding-based probes). For fluorescence-guided intraoperative surgery, enzyme-reactive probes are superior because they can react quickly, require smaller dosages especially for topical applications, have limited side effects, and have favorable pharmacokinetics. Enzyme-reactive probes are easier to use, fit better into existing work flows in the operating room and have minimal toxicity. Although difficult to prove, it is assumed that the guidance provided to surgeons by these probes results in more effective surgeries with better outcomes for patients. In this review, we compare these two types of activatable fluorescent probes for their ease of use and efficacy.

Indexed as

AnimalsAntibodies, MonoclonalEnzymesFluorescent DyesHumansLysosomesNeoplasmsAntibodies, MonoclonalEnzymesFluorescent DyesActivatable probesEnzyme-reactive activatable probesFluorescence-guided surgeryOptical fluorescence imagingTumor margin

Identifiers

PMID29242021
PMCPMC5820175

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.